Streetbeat News

Price Targets

WULF

Rosenblatt analyst Kevin Cassidy maintains a Buy rating on TeraWulf (NASDAQ:WULF) and raises the price target from $4.2 to $5.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:11 am

RPRX

Goldman Sachs analyst Chris Shibutani maintains a Buy rating on Royalty Pharma (NASDAQ:RPRX) and raises the price target from $50 to $51.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:10 am

LSXMK

Rosenblatt analyst Barton Crockett maintains a Buy rating on Liberty SiriusXM Group (NASDAQ: LSXMK) but lowers the price target from $29 to $28.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:09 am

MEG

Evercore ISI Group has initiated coverage on Montrose Environmental Group (NYSE:MEG) with an Outperform rating and a price target of $43.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:07 am

LBRDK

Rosenblatt analyst Barton Crockett maintains a Buy rating on Liberty Broadband (NASDAQ:LBRDK) and raises the price target from $80 to $91.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:07 am

BATRK

Rosenblatt analyst Barton Crockett maintains a Buy rating on Atlanta Braves Holdings (NASDAQ:BATRK) but lowers the price target from $54 to $53.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:04 am

STRO

HC Wainwright & Co. analyst Andrew Fein has reiterated a Buy rating on Sutro Biopharma (NASDAQ:STRO) and maintained a $12 price target.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:02 am

CRBU

HC Wainwright & Co. has reiterated its Buy rating on Caribou Biosciences (NASDAQ:CRBU) and maintained a price target of $9.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:00 am

ORIC

HC Wainwright & Co. analyst Robert Burns has reiterated a Buy rating on ORIC Pharmaceuticals (NASDAQ:ORIC) and maintained a $21 price target.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 10:59 am

LOW

Telsey Advisory Group has maintained its Market Perform rating and $230 price target for Lowe's Companies (NYSE:LOW). Analyst Joseph Feldman continues to see the stock as fairly valued at its current price.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 10:57 am